Last reviewed · How we verify
NCT05438017
Performance Evaluation of the Dreem 3 System for Sleep Assessment in Patients With Insomnia
NA trial testing Dreem 3 System vs PSG in Insomnia in 41 participants. Completed in 8 July 2022.
8 July 2022
Quick facts
| Lead sponsor | Dreem |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 41 |
| Start date | 21 April 2022 |
| Primary completion | 8 July 2022 |
| Estimated completion | 8 July 2022 |
| Sites | 2 locations across France, United States |
Drugs / interventions tested
- Dreem 3 System vs PSG
Conditions studied
- Insomnia — all drugs for Insomnia →
Sponsor
Dreem
Who can join
Adults 22 to 70, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the clinical investigation is to assess the performance of the Dreem 3 System for sleep assessment compared to a FDA-cleared PSG assessment and human sleep expert scoring in a population experiencing insomnia symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05438017
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insomnia
Currently open trials in the same condition.
- NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
- NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
- NCT07071324 — CF Wellness Program · NA · recruiting
- NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
- NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting
Other Dreem trials
Trials by the same sponsor.
- NCT05611099 — Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population. · NA · completed
- NCT03725943 — Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults · NA · completed
- NCT03657329 — Comparison of Dreem to Clinical PSG for Sleep Monitoring in Apnea Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05438017 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dreem
- Last refreshed: 29 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05438017.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing